Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review

Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). The risk of fatal recurrent VTE after treatment discontinuation (versus that of fatal bleeding during anticoagulation) is of particular relevance in the decision to continue or stop...

Full description

Bibliographic Details
Main Authors:	Sake J. van der Wall, Liselotte M. van der Pol, Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter, Sam Schulman, Paolo Prandoni, Marc Rodger, Menno V. Huisman, Frederikus A. Klok
Format:	Article
Language:	English
Published:	European Respiratory Society 2018-11-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/content/27/150/180094.full

Similar Items

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
by: Walter Ageno, et al.
Published: (2021-02-01)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
by: Bethany Samuelson Bannow, et al.
Published: (2021-07-01)

Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study
by: Noémie Kraaijpoel, et al.
Published: (2021-01-01)

Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE—Results from the ExACT randomised controlled trial.
by: Charlotte Bradbury, et al.
Published: (2019-12-01)

VTE risk assessment in pregnancy
by: Karl Ewins, et al.
Published: (2020-02-01)

Anticoagulation Therapy for Venous Thromboembolism in the Real World ― From the COMMAND VTE Registry ―
by: Yamashita, Yugo
Published: (2019)

Prevention of VTE in orthopedic surgery patients
by: Federico Spandonaro, et al.
Published: (2013-10-01)

Risk Assessment for Cancer-Associated VTE
by: Alok A. Khorana, MD
Published: (2021-09-01)

Metabolomic Profile in Venous Thromboembolism (VTE)
by: Beata Franczyk, et al.
Published: (2021-07-01)

Are we preventing VTE in patients with an infective exacerbation of chronic obstructive pulmonary disease - low adherence to VTE prophylaxis guidelines
by: Anmol Khanna
Published: (2016-12-01)

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
by: Walter Ageno, et al.
Published: (2017-06-01)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
by: Carlos Jerjes-Sánchez, et al.
Published: (2021-01-01)

SPECIFICITY OF ANTICOAGULANT CHOICE FOR VTE PROPHYLAXES AFTER MAJOR ORTHOPEDIC SURGERY- THE VIEW OF CLINICAL PHARMACOLOGISTS
by: S. A. Bozhkova
Published: (2011-03-01)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)

“What will happen in the future?” A personal VTE journey
by: Ellen O’Rourke, et al.
Published: (2020-12-01)

What’s new in VTE risk and prevention in orthopedic surgery
by: Susan R. Kahn, et al.
Published: (2020-03-01)

VTE Registry: What Can Be Learned from RIETE?
by: Inna Tzoran, et al.
Published: (2014-10-01)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
by: Frederikus A. Klok, et al.
Published: (2019-07-01)

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
by: Corinne Frere, et al.
Published: (2020-04-01)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
by: George Goshua, et al.
Published: (2021-01-01)

Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty
by: Jordan Etscheidt, et al.
Published: (2020-03-01)

Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum?
by: Sofya Pintova, et al.
Published: (2013-01-01)

MODIFICATION OF LITHIUM TANTALATE CRYSTALS BY HIGH-TEMPERATURE TREATMENT OF VTE
by: M.N. Palatnikov, et al.
Published: (2015-11-01)

Concordance of Identified Cases of Pediatric HA-VTE with American College of Physicians and Cincinnati Children’s Hospital HA-VTE Prophylaxis Guidelines Over a 10-Year Period
by: Elaine M. Fan MD, et al.
Published: (2020-10-01)

A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
by: Majid Mokhtari, et al.
Published: (2019-07-01)

Venous thromboembolism (VTE) prevention in orthopedics: facts, controversies, and evolving management
by: Langer JM, et al.
Published: (2012-09-01)

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
by: Silvia Riondino, et al.
Published: (2019-01-01)

A novel algorithm to reduce VTE in peri-operative patients on tamoxifen
by: Alexi Nicola, MBBCh, MRCS, et al.
Published: (2021-08-01)

Venous thromboembolic (VTE) prophylaxis in Cushing disease patients undergoing transsphenoidal surgery
by: Justin P. McCormick, et al.
Published: (2022-03-01)

Learning to become a Vocational and Technical Education (VTE) teacher in Brunei Darussalam
by: Goh, Adeline Yuen Sze
Published: (2010)

Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE
by: Ageno, W., et al.
Published: (2022)

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Application Prospect of Direct Oral Anticoagulant
by: Ruiheng JIANG, et al.
Published: (2019-12-01)

Design and synthesis of highly active MoVTeNb-oxides for ethane oxidative dehydrogenation
by: Daniel Melzer, et al.
Published: (2019-09-01)

The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment
by: Yan Qi MD, et al.
Published: (2020-10-01)

Perioperative Venous Thromboembolism (VTE) Prophalaxis  in Thoracic Cancer Patients: Chinese Experts Consensus
by: Hui LI, et al.
Published: (2018-10-01)

VTE Risk assessment – a prognostic Model: BATER Cohort Study of young women
by: Schürmann Rolf, et al.
Published: (2005-04-01)

Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis
by: Ben van Hout, et al.
Published: (2020-07-01)

Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis
by: Kristin S. Weeks, et al.
Published: (2020-01-01)

Incidence and risk factors of VTE in patients with cervical cancer using the Korean national health insurance data
by: Jin-Sung Yuk, et al.
Published: (2021-04-01)

Physicochemical properties of MoVTeNb mixed oxide catalysts synthesized using different vanadium sources
by: Haslinda Mohd Sidek, et al.
Published: (2021)